Zemplar and cardiac failure Patient Reports February 09, 2010

Zemplar Side Effects Report #5148210-2
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Oct 31, 2006. Female patient, weighting 244.7 lb, was diagnosed with renal failure chronic, hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure. Zemplar dosage: unknown. Patient was hospitalized. Patient died on 09/09/2006.

Zemplar Side Effects Report #5148866-4
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Oct 31, 2006. Female patient, weighting 244.7 lb, was diagnosed with renal failure chronic, hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure. Zemplar dosage: unknown. Patient was hospitalized. Patient died on 09/09/2006.

Zemplar Side Effects Report #5163076-2
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Oct 31, 2006. Female patient, weighting 244.7 lb, was diagnosed with renal failure chronic, hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure. Zemplar dosage: unknown. Patient was hospitalized. Patient died on 09/09/2006.

Zemplar Side Effects Report #5176645-0
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Oct 31, 2006. Female patient, weighting 244.7 lb, was diagnosed with renal failure chronic, hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: c-reactive protein increased, calciphylaxis, cardiac failure, diarrhoea, hyperparathyroidism secondary, international normalised ratio increased, oedema peripheral, pain in extremity, skin necrosis. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN BETA, SOTALOL HYDROCHLORIDE, FERRIECIT, GODASAL, NAHCO, CACO, SEVELAMER HYDROCHLORIDE. Patient was hospitalized. Patient died on 09/08/2006.

Zemplar Side Effects Report #5765868-5
Zemplar side effect was reported by a Physician from GERMANY on June 06, 2008. Female patient, 78 years of age, weighting 255.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure, pneumonia

. Zemplar dosage: unknown. During the same period patient was treated with CALCIUM ACETATE, DEDREI, BISOPROLOL FUMARATE, IRBESARTAN, AMITRIPTYLINE, SEVELAMER HYDROCHLORIDE, INSULIN. Patient died on 08/23/2006.

Zemplar Side Effects Report #5505857-9
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Oct 29, 2007. Female patient, 73 years of age, weighting 147.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure, congestive cardiomyopathy. Zemplar dosage: unknown. During the same period patient was treated with ANTIPHOSPHAT, OSTEOTRIOL, CARVEDILOL, DREISAVIT, OLMESARTAN MEDOXOMIL. Patient died on 08/01/2007.

Zemplar Side Effects Report #5513036-4
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Nov 05, 2007. Female patient, 73 years of age, weighting 147.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure, congestive cardiomyopathy. Zemplar dosage: unknown. During the same period patient was treated with ANTIPHOSPHAT, OSTEOTRIOL, CARVEDILOL, DREISAVIT, OLMESARTAN MEDOXOMIL. Patient died on 08/01/2007.

Zemplar Side Effects Report #5150065-7
Zemplar side effect was reported by a Physician from GERMANY on Sept 20, 2006. Female patient, 71 years of age, weighting 189.6 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure, hypertensive heart disease. Zemplar dosage: unknown. During the same period patient was treated with RENACET, METOPROLOL SUCCINATE, EPOETIN ALFA, THIAMAZOLE, PANTOPRAZOLE, SEVELAMER HYDROCHLORIDE, TRENTAL. Patient died on 03/10/2006.

Zemplar Side Effects Report #5100171-8
Zemplar side effect was reported by a Physician from GERMANY on Aug 28, 2006. Male patient, 46 years of age, weighting 271.2 lb, was diagnosed with hyperparathyroidism secondary, diabetes mellitus and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure, diabetic gangrene, hepatic failure, sepsis

. Zemplar dosage: unknown. During the same period patient was treated with PHOSPHOSORB, CALCITRIOL, COLECALCIFEROL, NPH INSULIN, DIGITOXIN, FOLIC ACID, LIPIDIL, METOPROLOL SUCCINATE. Patient was hospitalized. Patient died on 11/07/2005.

Zemplar Side Effects Report #5213615-8
Zemplar side effect was reported by a Physician from VENEZUELA on Jan 16, 2007. Male patient, weighting 112.4 lb, was diagnosed with hyperparathyroidism secondary, hypertrophic cardiomyopathy, vitamin supplementation, blood phosphorus and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure. Zemplar dosage: unknown. During the same period patient was treated with DIGOXIN, BECOSYMTE, FOLIC ACID, CALCIUM CARBONATE. Patient died on 11/20/2006.

Zemplar Side Effects Report #5253807-5
Zemplar side effect was reported by a Physician from GERMANY on Feb 19, 2007. Male patient, weighting 173.1 lb, was diagnosed with hyperparathyroidism secondary, coronary artery disease

, blood phosphorus increased, peripheral arterial occlusive disease and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure, hypertension, implantable defibrillator insertion. Zemplar dosage: unknown. During the same period patient was treated with ISOSORBIDE MONONITRATE, OMEPRAZOLE MAGNESIUM, ANTIPHOSPHATE, CLOPIDOGREL BISULPHATE, CLOPIDOGREL BISULPHATE, ACETYLSALICYLIC ACID SRT, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5285347-1
Zemplar side effect was reported by a Physician from GERMANY on Mar 27, 2007. Female patient, weighting 125.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure. Zemplar dosage: unknown. During the same period patient was treated with ALFACALCIDOL, AMIODARONE, ESOMEPRAZOLE MAGNESIUM, ACETYLSALICYLIC ACID SRT, BISOPROLOL, AMITRIPTYLINE, PREGABALIN, CELECOXIB. Patient died on 02/01/2007.

Zemplar Side Effects Report #5295606-4
Zemplar side effect was reported by a Physician from AUSTRIA on Apr 02, 2007. Female patient, weighting 166.4 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac disorder, cardiac failure. Zemplar dosage: unknown. During the same period patient was treated with NYCOC, DIGITOXIN, MOLSIDOMINE, FUROSEMIDE, ACETYLSALICYLIC ACID SRT, CLOPIDOGREL BISULPHATE. Patient died on 03/27/2007.

Zemplar Side Effects Report #5310513-6
Zemplar side effect was reported by a Physician from GERMANY on Apr 23, 2007. Female patient, weighting 125.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure. Zemplar dosage: unknown. During the same period patient was treated with ALFACALCIDOL, AMIODARONE, ESOMEPRAZOLE MAGNESIUM, ACETYLSALICYLIC ACID SRT, BISOPRODOL FUMARATE, AMITRIPTYLINE, PREGABALIN, CELECOXIB. Patient died on 02/01/2007.

Zemplar Side Effects Report #5322847-X
Zemplar side effect was reported by a Physician from AUSTRIA on May 02, 2007. Female patient, weighting 166.4 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac disorder, cardiac failure. Zemplar dosage: unknown. During the same period patient was treated with NYCOC, DIGITOXIN, MOLSIDOMINE, FUROSEMIDE, ACETYLSALICYLIC ACID SRT, CLOPIDOGREL BISULPHATE. Patient died on 03/27/2007.

Zemplar Side Effects Report #5084955-0
Zemplar side effect was reported by a Physician from GERMANY on Aug 11, 2006. Male patient, weighting 147.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood parathyroid hormone increased, blood phosphorus increased, cardiac failure, pulmonary congestion, shock, unevaluable event. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDE, ALUMINIUM HYDROXIDE GEL, VERAPAMIL HYDROCHLORIDE. Patient was hospitalized. Patient died on 05/12/2006.

Zemplar Side Effects Report #5092768-9
Zemplar side effect was reported by a Physician from GERMANY on Aug 11, 2006. Male patient, weighting 147.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood parathyroid hormone increased, blood phosphorus increased, cardiac failure, pulmonary congestion, shock, unevaluable event. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDE, ALUMINIUM HYDROXIDE GEL, VERAPAMIL HYDROCHLORIDE. Patient was hospitalized. Patient died on 05/12/2006.

Zemplar Side Effects Report #5116346-8
Zemplar side effect was reported by a Physician from GERMANY on Sept 11, 2006. Male patient, weighting 147.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure, confusional state, hypercalcaemia, psychotic disorder

. Zemplar dosage: unknown. Patient recovered.

Zemplar Side Effects Report #5156547-6
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Nov 13, 2006. Female patient, weighting 185.2 lb, was diagnosed with hyperparathyroidism secondary, cardiac failure, myocardial ischaemia, hypertension, bronchitis chronic and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure, intra-abdominal haemorrhage. Zemplar dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE, FUROSEMIDE, MOLSIDOMINE, AMINOPHYLLINE, WARFARIN. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5156549-X
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Nov 13, 2006. Female patient, weighting 198.4 lb, was diagnosed with hyperparathyroidism secondary, cardiac failure, myocardial ischaemia, hypertension, bronchitis chronic and was treated with Zemplar. After drug was administered, patient experienced the following side effects: atrial fibrillation

, cardiac failure, chest pain

, dyspnoea, inflammation, intra-abdominal haemorrhage, oedema, pelvic mass, pulse absent. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDE, MOLSIDOMINE, AMINOPHYLLINE, WARFARIN, FRAXIAPRIN. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5163116-0
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Nov 21, 2006. Male patient, weighting 110.2 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: blood pressure decreased, cardiac arrest

, cardiac failure, fall

, femur fracture, heart rate decreased, renal failure chronic. Zemplar dosage: unknown. Patient was hospitalized. Patient died on 11/15/2006.

Zemplar Side Effects Report #5505485-5
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Oct 24, 2007. Male patient, weighting 180.8 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure. Zemplar dosage: unknown. During the same period patient was treated with MAGNESIUM PHOSPHATE, BOCATRIOL, FERRLECIT, DARBEPOETIN ALFA. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5700344-7
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Mar 31, 2008. Male patient, weighting 143.3 lb, was diagnosed with hyperparathyroidism secondary, iron deficiency and was treated with Zemplar. After drug was administered, patient experienced the following side effects: atrial fibrillation

, cardiac failure, coronary artery disease

, diabetic gangrene, hypertension, myocardial infarction, peripheral arterial occlusive disease, sepsis

, type 2 diabetes mellitus. Zemplar dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, PENTAERITHRITYL TETRANITRATE, RAMIPRIL, SIMVASTATIN, THIAMAZOLE, EPOETIN BETA, FERRLECIT. Patient died on 07/23/2007.

Zemplar Side Effects Report #5705986-0
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 10, 2008. Male patient, weighting 137.1 lb, was diagnosed with hyperparathyroidism secondary, pain

, respiratory disorder, fluid retention and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure, renal disorder, respiratory failure. Zemplar dosage: unknown. During the same period patient was treated with VICODIN, DIAZEPAM, SERETIDE, SALBUTAMOL SULPHATE, LEVALBUTEROL, METOLAZONE, COMBIVENT, FORMOTEROL FUMARATE. Patient was hospitalized. Patient died on 03/08/2008.

Zemplar Side Effects Report #5711959-4
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2008. Male patient, weighting 137.1 lb, was diagnosed with hyperparathyroidism secondary, pain

, respiratory disorder, fluid retention and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure, lung disorder, renal disorder, respiratory failure. Zemplar dosage: unknown. During the same period patient was treated with VICODIN, DIAZEPAM, SERETIDE, SALBUTAMOL SULPHATE, LEVALBUTEROL, METOLAZONE, COMBIVENT, FORMOTEROL FUMARATE. Patient was hospitalized. Patient died on 03/08/2008.

Zemplar Side Effects Report #5740999-4
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on May 09, 2008. Female patient, weighting 125.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure, catheter related complication, dialysis device complication, fluid retention, hyperkalaemia, sepsis

. Zemplar dosage: unknown. During the same period patient was treated with ALFACALCIDOL, AMIODARONE, ESOMEPRAZOLE, ACETYLSALICYLIC ACID SRT, BISOPROLOL FUMARATE, AMITRIPTYLINE, PREGABALIN, CELECOXIB. Patient died on 02/01/2007.

Zemplar Side Effects Report #4960156-9
Zemplar side effect was reported by a Physician from GERMANY on Mar 22, 2006. Female patient, weighting 99.21 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure, pulmonary oedema. Zemplar dosage: unknown. During the same period patient was treated with MINPARA. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #4968356-9
Zemplar side effect was reported by a Physician from GERMANY on Mar 22, 2006. Female patient, weighting 99.21 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure, pulmonary oedema. Zemplar dosage: unknown. During the same period patient was treated with MINPARA. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #4974453-4
Zemplar side effect was reported by a Physician from SPAIN on Mar 28, 2006. Male patient, weighting 123.5 lb, was diagnosed with hyperparathyroidism secondary, hyperphosphataemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, cardiac failure, congestive cardiomyopathy, dyspnoea, electrocardiogram st segment elevation, ischaemic cardiomyopathy, mitral valve incompetence, oedema peripheral, orthopnoea. Zemplar dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, FOLIC ACID, TAMSULOSIN, VITAMINES, OMEPRAZOLE, EPOETIN ALFA, SEVELAMER HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5838774-5
Zemplar side effect was reported by a Physician from AUSTRIA on July 29, 2008. Female patient, 84 years of age, weighting 178.6 lb, was diagnosed with hyperparathyroidism, atrial fibrillation

and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure, coronary artery disease

, pyrexia, skin ulcer. Zemplar dosage: unknown. During the same period patient was treated with AMIODARONE. Patient died on 12/07/2005.

Zemplar Side Effects Report #5839155-0
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Aug 04, 2008. Male patient, 63 years of age, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure. Zemplar dosage: 10MCG/WEEK; 5MCG/ML. During the same period patient was treated with ENALAPRIL MALEATE, SIMVASTATIN, PREDNISOLONE PHOSPHATE, TACROLIMUS, ALLOPURINOL, LOPERAMIDE HYDROCHLORIDE, NITROGLYCERIN. Patient recovered.

Zemplar Side Effects Report #5676936-0
Zemplar side effect was reported by a Consumer or non-health professional from AUSTRIA on Mar 17, 2008. Male patient, 47 years of age, weighting 170.9 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure. Zemplar dosage: unknown. During the same period patient was treated with ARNESEP, CLOPIDOGREL, CYCLOSPORINE, SELOKEN RETARD, ASPIRIN. Patient died on 02/04/2008.

Zemplar Side Effects Report #5374147-X
Zemplar side effect was reported by a Physician from GERMANY on June 21, 2007. Male patient, weighting 176.4 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure. Zemplar dosage: unknown. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #6037438-5
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 12, 2009. Female patient was diagnosed with hyperparathyroidism, renal failure and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac failure, gallbladder disorder. Zemplar dosage: unknown. During the same period patient was treated with CAPTOPRIL, LASIX, COUMADIN, LIPITOR, COREG, LEXAPRO. Patient died on 01/08/2009.

Zemplar and cardiac failure

SideEffects101.com

Zemplar and cardiac failure Patient Reports February 09, 2010

side effects of Zemplar